Work

Severe neutropenia during cabazitaxel treatment is associated with survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TROPIC phase III trial

Year: 2016

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2015.12.009

Authors: Alexander Meisel, Stefanie von Felten, Deborah R. Vogt, Heike Liewen, Ronald de Wit, Johann de Bono, Oliver Sartor, Frank Stenner-Liewen

Institutions: University Hospital Zurich, Stadtspital Waid, University Hospital of Basel, Erasmus MC, Erasmus MC Cancer Institute, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Tulane University, Tulane Medical Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Sanofi

OpenAlex ID: W2261919111

FWCI: 11.02

Cites: 33

Cited by: 78

Related to: 10